[go: up one dir, main page]

FI972235L - Förfarande för användning av triaryletylenderivat vid behandling och förhindrande av osteoporos - Google Patents

Förfarande för användning av triaryletylenderivat vid behandling och förhindrande av osteoporos Download PDF

Info

Publication number
FI972235L
FI972235L FI972235A FI972235A FI972235L FI 972235 L FI972235 L FI 972235L FI 972235 A FI972235 A FI 972235A FI 972235 A FI972235 A FI 972235A FI 972235 L FI972235 L FI 972235L
Authority
FI
Finland
Prior art keywords
osteoporosis
prevention
treatment
triarylethylene
derivatives
Prior art date
Application number
FI972235A
Other languages
English (en)
Finnish (fi)
Other versions
FI972235A0 (sv
Inventor
Alan J Bitonti
Original Assignee
Hoechst Marion Roussel Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/531,885 external-priority patent/US5691384A/en
Application filed by Hoechst Marion Roussel Inc filed Critical Hoechst Marion Roussel Inc
Publication of FI972235L publication Critical patent/FI972235L/sv
Publication of FI972235A0 publication Critical patent/FI972235A0/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/136—Amines having aromatic rings, e.g. ketamine, nortriptyline having the amino group directly attached to the aromatic ring, e.g. benzeneamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4453—Non condensed piperidines, e.g. piperocaine only substituted in position 1, e.g. propipocaine, diperodon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FI972235A 1994-11-29 1997-05-27 Förfarande för användning av triaryletylenderivat vid behandling och förhindrande av osteoporos FI972235A0 (sv)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US34611194A 1994-11-29 1994-11-29
US08/531,885 US5691384A (en) 1994-11-29 1995-10-11 Method of using triaryl-ethylene derivatives in the treatment and prevention of osteoporosis
PCT/US1995/013873 WO1996016646A1 (en) 1994-11-29 1995-10-27 Method of using triaryl-ethylene derivatives in the treatment and prevention of osteoporosis

Publications (2)

Publication Number Publication Date
FI972235L true FI972235L (sv) 1997-05-27
FI972235A0 FI972235A0 (sv) 1997-05-27

Family

ID=26994698

Family Applications (1)

Application Number Title Priority Date Filing Date
FI972235A FI972235A0 (sv) 1994-11-29 1997-05-27 Förfarande för användning av triaryletylenderivat vid behandling och förhindrande av osteoporos

Country Status (12)

Country Link
US (1) US5693674A (sv)
EP (1) EP0794771A1 (sv)
JP (1) JPH10509962A (sv)
CN (1) CN1167437A (sv)
AU (1) AU707290B2 (sv)
CA (1) CA2206422A1 (sv)
FI (1) FI972235A0 (sv)
HU (1) HUT77603A (sv)
IL (1) IL116142A0 (sv)
MX (1) MX9703944A (sv)
NO (1) NO972426L (sv)
WO (1) WO1996016646A1 (sv)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7005428B1 (en) 1998-06-11 2006-02-28 Endorecherche, Inc. Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors
US6465445B1 (en) 1998-06-11 2002-10-15 Endorecherche, Inc. Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors
TW593256B (en) 1999-11-16 2004-06-21 Hormos Medical Oy Ltd Triphenylalkene derivatives and their use as selective estrogen receptor modulators
US20040248989A1 (en) 2003-06-05 2004-12-09 Risto Santti Method for the treatment or prevention of lower urinary tract symptoms
MX2008014825A (es) * 2006-05-22 2008-12-01 Hormos Medical Ltd Moduladores selectivos del receptor de estrogeno o inhibidores de aromatasa para tratar prostatitis cronica no bacteriana.
WO2008099060A2 (en) * 2007-02-14 2008-08-21 Hormos Medical Ltd Methods for the preparation of fispemifene from ospemifene
WO2008099059A1 (en) * 2007-02-14 2008-08-21 Hormos Medical Ltd Method for the preparation of therapeutically valuable triphenylbutene derivatives
MX2010014372A (es) 2008-07-02 2011-06-20 British Columbia Cancer Agency Agentes terapeuticos derivados de eter diglicidico y métodos para su uso.
JP6174156B2 (ja) 2012-10-19 2017-08-02 フェルミオン オサケ ユキチュア オスペミフェンの製造方法
CA2973036A1 (en) * 2015-01-13 2016-07-21 British Columbia Cancer Agency Branch Heterocyclic compounds for cancer imaging and treatment and methods for their use
WO2016141458A1 (en) 2015-03-12 2016-09-15 British Columbia Cancer Agency Branch Bisphenol ether derivatives and methods for using the same
US20170298033A1 (en) 2016-04-15 2017-10-19 The University Of British Columbia Bisphenol derivatives and their use as androgen receptor activity modulators
US11485713B2 (en) 2018-05-25 2022-11-01 Essa Pharma, Inc. Androgen receptor modulators and methods for their use
CN113195441B (zh) 2018-10-18 2024-07-12 埃萨制药股份有限公司 雄激素受体调节剂及其使用方法
WO2020198712A1 (en) 2019-03-28 2020-10-01 Essa Pharma, Inc. Pharmaceutical compositions and combinations comprising inhibitors of the androgen receptor and uses thereof
WO2021212032A1 (en) 2020-04-17 2021-10-21 Essa Pharma, Inc. Solid forms of an n-terminal domain androgen receptor inhibitor and uses thereof

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2914563A (en) * 1957-08-06 1959-11-24 Wm S Merrell Co Therapeutic composition
GB1013907A (en) * 1962-09-13 1965-12-22 Ici Ltd Alkene derivatives
US3247252A (en) * 1962-11-14 1966-04-19 Richardson Merrell Inc Beta-dialkylaminoethylamino-triphenylethanols, -ethanes, and -ethenes
GB1099093A (en) * 1965-09-03 1968-01-17 Ici Ltd Alkene derivatives
GB1128379A (en) * 1966-06-20 1968-09-25 Ici Ltd Novel alkene derivatives, process for the preparation thereof and compositions containing the same
US4001229A (en) * 1974-04-04 1977-01-04 Mead Johnson & Company Alkanesulfonamido triphenylethylenes
EP0002097B1 (en) * 1977-08-22 1981-08-05 Imperial Chemical Industries Plc Triphenylalkene derivatives, process for their preparation and pharmaceutical compositions containing them
US4729999A (en) * 1984-10-12 1988-03-08 Bcm Technologies Antiestrogen therapy for symptoms of estrogen deficiency
US4970237A (en) * 1987-03-20 1990-11-13 Yale University Use of clomiphene to increase bone mass in premenopausal women
JPH06312930A (ja) * 1993-04-30 1994-11-08 Kuraray Co Ltd 骨粗鬆症治療剤
US5525633A (en) * 1993-09-24 1996-06-11 Merrell Dow Pharmaceuticals Inc. Triaryl-ethylene derivatives
ZA956029B (en) * 1994-07-22 1997-01-20 Lilly Co Eli Combination treatment for inhibiting bone loss

Also Published As

Publication number Publication date
IL116142A0 (en) 1996-01-31
NO972426D0 (no) 1997-05-28
HUT77603A (hu) 1998-06-29
AU4196796A (en) 1996-06-19
JPH10509962A (ja) 1998-09-29
WO1996016646A1 (en) 1996-06-06
CA2206422A1 (en) 1996-06-06
NO972426L (no) 1997-07-29
CN1167437A (zh) 1997-12-10
EP0794771A1 (en) 1997-09-17
FI972235A0 (sv) 1997-05-27
AU707290B2 (en) 1999-07-08
US5693674A (en) 1997-12-02
MX9703944A (es) 1998-05-31

Similar Documents

Publication Publication Date Title
FI971969A0 (sv) Kompositioner för behandling av hemorrojder och användningsmetod
EE03399B1 (et) Teraapias kasutatavad spiro-asabitsüklilised ühendid ja nende valmistamise protsess
FI972260L (sv) Anordning och förfarande för behandling av ytor
EE9700114A (et) Meetod ja seade heitvee töötlemiseks
BR9407799A (pt) Composição de matéria método de tratamento e composição farmaceutica
FI973378A0 (sv) Anordning och förfarande
FI951305L (sv) Medicinskt material och förfarande för framställning därav
EP1027016A4 (en) METHODS AND PHARMACEUTICAL COMPOSITIONS FOR REFERRING RETINAL RIPPLE
EE9900247A (et) Arvutamiseks kasutatav meetod ja aparatuur
FI972235L (sv) Förfarande för användning av triaryletylenderivat vid behandling och förhindrande av osteoporos
EE9800234A (et) Ravimeetod ja farmatseutiline kompositsioon
FI972919A (sv) Indolderivat användbara vid behandling av osteoporos
FI980246A (sv) Förfarande för driften av en kokare och kokare
FI916112L (sv) Sliphjälpmedel och förfarande för slipning användande detsamma
FI955426L (sv) Ytbehandlingsprodukter och förfaranden för deras framställning
FI951060L (sv) Formulationer och behandlingsmetoder
EE9700198A (et) Meetod ja aparatuur orgaaniliste jäätmete töötlemiseks
FI962538L (sv) Förfarande och anordning för hantering av vätskor
FI960835L (sv) Anordning och förfarande för att finfördela material
EE9800164A (et) Farmatseutiline kompositsioon ja meetod epitelioomi raviks
HU9502722D0 (en) Amino-methyl-phosphonic- and amino-methyl-phosphinic-acid derivatives and their use for treating degenerative membrum diseases
BR9710544A (pt) M-todo de tratamento composto e composi-Æo farmac-utica
FI955123A0 (sv) Komposition innehållande kolestyramin och förfarande för framställning av densamma
FI954408L (sv) Anordning och förfarande för stekning
FI944687L (sv) Sammansättning för profylax och behandling av närsynthet